Your browser doesn't support javascript.
loading
Early predictors of intensive care unit admission among COVID-19 patients in Qatar.
Abuyousef, Safae; Alnaimi, Shaikha; Omar, Nabil E; Elajez, Reem; Elmekaty, Eman; Abdelfattah-Arafa, Eiman; Barazi, Raja; Ghasoub, Rola; Rahhal, Ala; Hamou, Fatima; Al-Amri, Maha; Karawia, Ahmed; Ajaj, Fatima; Alkhawaja, Raja; Kardousha, Ahmed; Awaisu, Ahmed; Abou-Ali, Adel; Khatib, Mohamad; Aboukamar, Mohammed; Al-Hail, Moza.
Affiliation
  • Abuyousef S; Department of Pharmacy, Heart Hospital, Hamad Medical Corporation, Doha, Qatar.
  • Alnaimi S; Department of Pharmacy, Hamad Bin Khalifa Medical City, Hamad Medical Corporation, Doha, Qatar.
  • Omar NE; Department of Pharmacy, National Centre for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
  • Elajez R; Health Sciences Program, Clinical and Population Health Research, College of Pharmacy, Qatar University, Doha, Qatar.
  • Elmekaty E; Department of Pharmacy, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.
  • Abdelfattah-Arafa E; Department of Pharmacy, Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar.
  • Barazi R; Department of Pharmacy, Al-Khor Hospital, Hamad Medical Corporation, Doha, Qatar.
  • Ghasoub R; Department of Pharmacy, Al Wakra Hospital, Hamad Medical Corporation, Doha, Qatar.
  • Rahhal A; Department of Pharmacy, National Centre for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
  • Hamou F; Department of Pharmacy, Heart Hospital, Hamad Medical Corporation, Doha, Qatar.
  • Al-Amri M; Department of Pharmacy, Heart Hospital, Hamad Medical Corporation, Doha, Qatar.
  • Karawia A; Department of Pharmacy, Heart Hospital, Hamad Medical Corporation, Doha, Qatar.
  • Ajaj F; Department of Pharmacy, Rumailah Hospital, Hamad Medical Corporation, Doha, Qatar.
  • Alkhawaja R; Department of Pharmacy, Home Health Care, Hamad Medical Corporation, Doha, Qatar.
  • Kardousha A; Department of Pharmacy, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.
  • Awaisu A; Department of Pharmacy, National Centre for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
  • Abou-Ali A; College of Pharmacy, QU Health, Qatar University, Doha, Qatar.
  • Khatib M; Astellas Pharma Global Development, Inc., Northbrook, IL, United States.
  • Aboukamar M; Department of Critical Care, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.
  • Al-Hail M; Department of Infectious Disease, Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar.
Front Public Health ; 12: 1278046, 2024.
Article in En | MEDLINE | ID: mdl-38572008
ABSTRACT

Background:

COVID-19 is associated with significant morbidity and mortality. This study aimed to explore the early predictors of intensive care unit (ICU) admission among patients with COVID-19.

Methods:

This was a case-control study of adult patients with confirmed COVID-19. Cases were defined as patients admitted to ICU during the period February 29-May 29, 2020. For each case enrolled, one control was matched by age and gender.

Results:

A total of 1,560 patients with confirmed COVID-19 were included. Each group included 780 patients with a predominant male gender (89.7%) and a median age of 49 years (interquartile range = 18). Predictors independently associated with ICU admission were cardiovascular disease (adjusted odds ratio (aOR) = 1.64, 95% confidence interval (CI) 1.16-2.32, p = 0.005), diabetes (aOR = 1.52, 95% CI 1.08-2.13, p = 0.016), obesity (aOR = 1.46, 95% CI 1.03-2.08, p = 0.034), lymphopenia (aOR = 2.69, 95% CI 1.80-4.02, p < 0.001), high AST (aOR = 2.59, 95% CI 1.53-4.36, p < 0.001), high ferritin (aOR = 1.96, 95% CI 1.40-2.74, p < 0.001), high CRP (aOR = 4.09, 95% CI 2.81-5.96, p < 0.001), and dyspnea (aOR = 2.50, 95% CI 1.77-3.54, p < 0.001).

Conclusion:

Having cardiovascular disease, diabetes, obesity, lymphopenia, dyspnea, and increased AST, ferritin, and CRP were independent predictors for ICU admission in patients with COVID-19.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Health context: 4_TD / 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Cardiovascular Diseases / Diabetes Mellitus / COVID-19 / Lymphopenia Limits: Adult / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Front Public Health Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 4_TD / 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Cardiovascular Diseases / Diabetes Mellitus / COVID-19 / Lymphopenia Limits: Adult / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Front Public Health Year: 2024 Document type: Article